mAb: To block extracellular signaling
Advantage:
High binding affinity;
Prolonged Long duration of pharmacokinetic profile
Disadvantage:
Inability to cross cell membranes
Need for parenteral delivery
High "cost of goods"
Few established targets, primarily acts on the cell surface